Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ECX
ECX logo

ECX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ecarx Holdings Inc. (ECX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.080
1 Day change
-5.26%
52 Week Range
2.700
Analysis Updated At
2026/05/08
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

ECX is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The stock has some short-term momentum, but the broader technical trend is still weak, fundamentals are mixed, and there are no strong proprietary buy signals. My direct view is hold, not buy.

Technical Analysis

Price closed at 1.19, slightly above the previous close of 1.18, with regular session strength of 5.36%. MACD histogram is positive and expanding, which supports near-term momentum. However, RSI_6 at 65.46 is only moderately bullish and not deeply oversold or strongly overbought. The key issue is that moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, indicating the longer-term trend is still down. Pivot support/resistance is tight around 1.143 support and 1.224 resistance, so the stock is trading near a short-term decision zone rather than in a confirmed uptrend.

Positive Catalysts

  • Revenue in 2025/Q4 increased 12.91% year over year, showing growth in sales. MACD is positive and expanding, suggesting improving short-term momentum. The stock also showed a strong regular session gain relative to the market, which may indicate some near-term accumulation.

Neutral/Negative Catalysts

  • Net income fell sharply to 2.57 million, down 146.79% YoY, and EPS declined 150.00% YoY, showing weaker profitability. Gross margin also compressed to 20.9%, down 1.74% YoY. There was no news in the recent week, no meaningful hedge fund or insider activity, and no recent congress trading data. The broader technical trend remains bearish because longer-term moving averages are still stacked negatively.

Financial Performance

Latest quarter: 2025/Q4. Revenue grew to 304,658,000, up 12.91% YoY, which is a positive top-line trend. However, profitability deteriorated materially: net income dropped to 2,557,000, EPS fell to 0.01, and gross margin declined to 20.9%. Overall, the latest quarter shows growth in sales but weaker earnings quality and margin pressure.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data was provided, so there is no clear Wall Street upgrade/downgrade trend to report. Based on the available information, Wall Street pros would likely see the main positive as revenue growth, but the main negatives are falling profitability, margin compression, and a still-bearish technical structure. Net view: cautious to neutral rather than bullish.

Wall Street analysts forecast ECX stock price to rise
Analyst Rating
0
Wall Street analysts forecast ECX stock price to rise
Buy
Hold
Sell
0
Current: 1.140
sliders
Low
0
Averages
0
High
0
0
Current: 1.140
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch